Investing.com-- U.S. President Donald Trump said on Monday evening that his administration was working with major American ...

Investing.com-- China and Southeast Asian equities are likely to lead Asia’s markets in 2026, underpinned by supportive liquidity, industrial discipline, and a policy pivot toward reform aimed at ...

Investing.com-- AbbVie Inc (NYSE:ABBV) said on Monday evening it reached a deal with the Donald Trump administration to cut the prices of its treatments in Medicaid, with the drugmaker also pledging a ...

Investing.com-- Lynas Rare Earths Ltd (ASX:LYC) said on Tuesday CEO and Managing Director Amanda Lacaze will retire after 12 years in the role, although she will stay with the company until the end of ...

Richard Francis, senior director at Fitch Ratings, stated in emailed comments that the credit rating agency will continue to monitor the evolution of governance, including "institutional checks and ...

Investing.com -- First Manhattan, a $36B+ independently owned investment advisory firm, announced Monday that Adam Yale has ...

"Effective immediately, any Country doing business with the Islamic Republic of Iran will pay a Tariff of 25% on any and all business being done with the United States of America. This Order is final ...

The home goods retailer has co-developed Google’s Universal Commerce Protocol (UCP), an open standard that aims to enable ...

Investing.com -- OpenAI has acquired Torch Health in a deal valued at $100 million, according to a report from The Information. The Torch Health team will join OpenAI to help develop ChatGPT Health ...

Investing.com -- The Federal Communications Commission revised a rule on Monday that required Verizon Communications (NYSE:VZ ...

Investing.com -- U.S. Treasury Secretary Scott Bessent told President Donald Trump that the federal investigation into Federal Reserve Chair Jerome Powell "made a mess" and could negatively impact ...

Investing.com -- BioAge Labs, Inc. (NASDAQ:BIOA) stock surged 21% Monday after the clinical-stage biopharmaceutical company announced additional positive interim data from its Phase 1 trial of BGE-102 ...